ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1418 National Cancer Institute Html en Cancer-Related Post-traumatic Stress (PDQ®)–Patient Version Shock, fear, helplessness, or horror can be felt by cancer patients at any time and lead to cancer-related post-traumatic stress. Learn about the causes and ways doctors can help manage these symptoms of distress in this expert-reviewed summary.
cancer treatment0.338437
life-threatening stress0.303648
natural disasters0.295492
PDQ cancer information0.517368
upsetting event0.305231
clinical trial search0.288109
certain triggers0.298605
stressful events0.297941
clinical trials0.416557
cancer information summary0.420357
clinical trial0.342943
breast cancer prevention0.304611
PDQ summaries0.31577
patients0.413744
cancer patients0.39239
latest published information0.297252
childhood cancer survivors0.334732
cancer-related PTS0.301933
NCI’s PDQ0.315928
NCI PDQ cancer0.384736
cancer survivors0.382895
violent personal attack0.28851
cancer-related post-traumatic stress0.771546
Breast cancer survivors0.324986
treatment0.388516
post-traumatic stress disorder0.44428
cancer prevention0.308777
cancer experience0.306174
anxiety disorders0.288817
Cancer Information Service0.325795
PDQ Supportive0.310148
treatment clinical trials0.303343
National Cancer Institute0.448327
post-traumatic stress symptoms0.498161
PDQ documents0.307297
early symptoms0.28734
Palliative Care Editorial0.346292
new treatment0.299459
possible cancer recurrence0.324764
PDQ database0.313308
Cancer Care page0.31311
Care Editorial Board0.347322
PDQ summary0.393635
PTSD0.349898
PTSD).0.290236
cancer clinical trials0.330243
cancer information summaries0.334057
comprehensive cancer information0.334182
CLICK HERE
1491 National Cancer Institute Html en Laryngeal Cancer Treatment (PDQ®)–Health Professional Version Expert-reviewed information summary about the treatment of laryngeal cancer.
Elective neck radiation0.612858
locally advanced head0.629434
radiation therapy-based treatment0.65069
randomized controlled trials0.580539
Engl J Med0.592068
advanced laryngeal cancer0.614525
radiation therapy.0.583072
Laryngeal Cancer Study0.614831
laryngeal cancer0.719655
Int J Radiat0.605237
randomized study0.574463
Radiation Therapy Oncology0.613999
neck cancer patients0.594571
Radiat Oncol Biol0.689017
induction chemotherapy group0.591432
patients0.718736
initial radiation0.58218
standard treatment options0.574341
lymph nodes0.592104
early-stage larynx cancer0.642059
radiation therapy0.991511
beam radiation therapy0.610314
et al.0.672465
concomitant chemotherapy0.657903
larynx cancer0.643614
Affairs Laryngeal Cancer0.575648
radiation failures0.582504
altered fractionation radiation0.602814
intensity-modulated radiation therapy0.607841
laryngeal cancers0.598434
Concurrent radiation therapy0.626365
advanced larynx cancer0.579933
radiation field0.584791
high local control0.57619
definitive radiation therapy0.62584
local control0.651065
external-beam radiation therapy0.622106
early-stage laryngeal cancer0.582781
Oncol Biol Phys0.693462
lymph node involvement0.5855
particle-beam radiation therapy0.628769
neck cancer0.66828
lymph node0.614894
treatment options0.588529
local progression-free survival0.574463
induction chemotherapy0.734401
Cancer Study Group0.595423
squamous cell carcinoma0.619401
CLICK HERE
1755 National Cancer Institute Html en Genetic Testing for Hereditary Cancer Syndromes A fact sheet about genetic testing for inherited cancer risk. Includes types of tests, who should consider testing, and how to understand test results.
negative test result0.400337
health care provider0.502328
genetic mutation0.416497
family member0.418619
harmful genetic mutation0.411753
cancer-predisposing mutation0.409751
hereditary cancer disorders0.398762
hereditary cancer syndromes0.681889
cancer risk condition0.40678
health care providers0.394471
hereditary cancer syndrome0.621674
family members0.522464
test results0.569131
major hereditary cancer0.393709
possible cancer risk0.406537
certain hereditary cancer0.433421
cancer types0.481189
DTC genetic tests0.42978
person0.492341
Genetic Information Nondiscrimination0.390123
genetic tests0.554486
specific genetic change0.3911
specific cancer type0.391368
genetic counselor0.453074
male breast cancer0.389105
DTC genetic testing0.513411
genetic counseling0.415519
disease-related genetic mutation0.41195
family medical history0.39883
positive test result0.403147
common inherited cancer0.408932
particular genetic test0.407943
inherited genetic variants0.392436
genetic information0.399804
health care0.626411
genetic test results0.557316
genetic change0.403267
at-home genetic testing0.430532
prenatal genetic test0.402782
genetic mutations0.44962
breast cancer0.417779
Hereditary breast cancer0.406679
people0.398079
health care decisions0.427407
genetic testing0.952895
cancer risk0.555583
hereditary cancer0.711991
cancer0.86681
information0.408541
CLICK HERE
1769 National Cancer Institute Html es Humo de tabaco en el ambiente y el cáncer Hoja informativa que resume los estudios sobre los efectos para la salud de la exposición al humo de tabaco en el ambiente.
Protección Ambiental0.571939
única forma0.552366
organiza reuniones0.546237
vías respiratorias0.568775
Estados Unidos0.886156
Healthy People0.776058
ambiente causa0.925234
programa nacional0.64248
CLICK HERE
1818 National Cancer Institute Html es Tratamiento del cáncer de paratiroides (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca del tratamiento del cáncer de paratiroides.
Parathyroid carcinoma versus0.314395
Lippincott Williams0.313221
interdisciplinary management0.305907
Lumachi F0.309431
carcinoma with tc-99m0.305998
Functioning parathyroid carcinoma0.307209
Favia G0.309942
American Cancer Society0.316114
Cancer Data Base0.316291
metastasis from parathyroid0.30974
postoperative parathyroid carcinoma0.307215
Fleming ID0.306345
Hundahl SA0.306222
Data Base Report0.311266
DeVita VT Jr0.324372
Radiat Oncol Biol0.307199
glándulas paratiroides0.306363
from parathyroid carcinoma0.319948
parathyroid tumors0.321669
Clinical review0.314388
parathyroid carcinoma0.98314
Prognostic factors0.306954
Sandelin K0.34021
metastatic parathyroid carcinoma0.313321
Bondeson L0.30997
Rosenberg SA0.31229
Clin Endocrinol Metab0.394458
Lawrence TS0.312691
National Cancer0.333111
parathyroid carcinoma with0.31437
parathyroid adenoma0.30731
Bilezikian JP0.306387
carcinoma paratiroideo0.32174
National Cancer Database0.307384
primary hyperparathyroidism0.309819
Surg Oncol0.319122
Busaidy NL0.306079
National Cancer Data0.316413
carcinoma versus parathyroid0.314395
Fremgen AM0.306349
Auer G0.3065
9th ed0.313566
pulmonary metastasis from0.306768
Kebebew E0.312769
Oncol Biol Phys0.30731
Surgeons Commission0.306833
Princess Margaret Hospital0.306413
recurrent parathyroid carcinoma0.307247
parathyroid carcinoma treated0.330169
CLICK HERE
1862 National Cancer Institute Html es Tratamiento del cáncer de uretra (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca del tratamiento del cáncer de uretra.
urethral tumors0.342422
secciones distal0.323073
Lippincott Williams0.35647
Lin DW0.322871
papillomaviruses with carcinomas0.32226
transitional cell carcinoma0.357652
Ta Carcinoma0.32924
Gomella LG0.359219
urethral tumor involvement0.329567
7th ed0.322172
Coordinated chemoradiation therapy0.336249
Instituto Nacional0.32668
DeVita VT Jr0.40337
urethra with chemotherapy0.34093
chemoradiation therapy with0.337618
Karnes RJ0.33747
plus infusional high0.33117
Porter MP0.322353
Rosenberg SA0.353321
Male urethral carcinoma0.339582
Breau RH0.33767
tercio distal0.368197
Lawrence TS0.353966
urethral carcinoma0.638147
United States0.321915
End Results0.324443
Urol Clin North0.656789
Koontz BF0.336415
primary urethral carcinoma0.381596
lesiones tis0.323889
Cancer Staging Manual0.353458
lesiones t30.324367
radiation oncology0.341092
lesiones t10.339652
Female urethral carcinoma0.338979
primary invasive carcinoma0.362458
Lee WR0.334415
uretra distal0.976805
Swartz MA0.321742
9th ed0.357004
Clin North Am0.654236
Successful treatment0.323556
numerosas glándulas0.322763
Lightner DJ0.335736
tis pd carcinoma0.335113
Zhang ZF0.322598
Tis Carcinoma0.330085
metastatic urothelial carcinoma0.358216
AJCC Cancer Staging0.35514
CLICK HERE
1896 National Cancer Institute Html es Tratamiento del cáncer de páncreas (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento del cáncer de páncreas.
estadio lV0.425648
pequeñas incisiones0.367032
aguja fina0.488715
siguientes procedimientos0.412593
Estadio IA0.426998
estadio iv0.507764
siguientes aspectos0.382876
Ecografía abdominal0.386812
estadio ii0.546166
células endocrinas0.43128
causa ictericia0.369929
estadios ia0.357173
siguientes tipos0.356896
Estadio IIA0.42546
rayos x0.367548
enlace drugs approved0.5669
melanoma familiar atípico0.436475
ondas sonoras0.371814
cercanos.ampliar cáncer0.946814
tumores neuroendocrinos0.380539
National Cancer Institute0.355543
estadio lB0.430806
tejidos cercanos.ampliar cáncer0.74829
endocrina múltiple tipo0.4367
Instituto Nacional0.397986
estadios iia0.360412
PDQ Tratamiento0.883614
presente sumario0.428926
oculto detrás0.371225
antecedentes familiares0.366146
Colangiopancreatografía retrógrada0.374947
Elabora hormonas0.377934
estadio llA0.424706
explorador tep0.376314
Pancreatectomía distal0.35778
Physician Data Query0.499092
Pancreatic Cancer0.442415
enzimas pancreáticas0.350126
estadio iii0.513007
Cirugía paliativa0.414657
antígeno carcinoembrionario0.380177
von hippel-lindau0.376964
ovario hereditario0.376013
linfáticos cercanos.ampliar cáncer0.783386
siguientes pruebas0.38409
CLICK HERE
1904 National Cancer Institute Html es Tratamiento del cáncer epitelial de ovario, de trompa de Falopio y primario de peritoneo (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento del cáncer epitelial de ovario, de trompa de Falopio y primario de peritoneo.
siguientes procedimientos0.423688
quimioterapia ip0.416839
estadios ii0.409427
siguientes aspectos0.416771
causa hinchazón0.412974
Ecografía abdominal0.413715
rayos x0.41264
estadio ic0.511392
estadio ivb0.503452
estadio ib0.512383
estadio ia0.511445
enlace drugs approved0.449365
Fallopian Tube0.428306
ondas sonoras0.413458
estadio iva0.501667
National Cancer Institute0.410523
Primary Peritoneal Cancer0.449696
siguientes riesgos0.40878
realidad células0.424697
siguientes tratamientos0.411661
Instituto Nacional0.43725
estadio iiia0.506125
PDQ Tratamiento0.420853
estadio iiic0.505194
ganglios linfáticos detrás0.603433
estadio iiib0.505868
estadio iia0.510869
estadio iib0.511005
Physician Data Query0.437199
or primary peritoneal0.450381
estadio iii0.551718
peritoneo causa efectos0.460442
siguientes situaciones0.416252
cuello uterino0.944087
ovario.ampliar anatomía0.415019
PDQ Prevención0.426006
histerectomía laparoscópica total.Ampliar0.422039
siguientes enlaces0.409849
ecografía transvaginal.Ampliar0.413879
histerectomía abdominal0.414317
genes brca10.412481
siguientes sumarios0.425477
siguientes pruebas0.420302
CLICK HERE
1969 National Cancer Institute Html es Tratamiento del sarcoma de tejido blando en adultos (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento del sarcoma de tejido blando en adultos.
estadio lV0.482165
siguientes procedimientos0.954883
estadio iv0.615433
siguientes elementos0.511302
Neurofibromatosis tipo0.50222
von recklinghausen0.491269
estadios ia0.468147
vía oral0.457153
estadio il0.488391
rayos x0.474452
único tratamiento0.566108
estadio ib0.532006
menor cantidad0.562912
estadio ia0.530637
carcinoma nevoide0.493219
National Cancer Institute0.451467
siguientes riesgos0.443955
Instituto Nacional0.590522
PDQ Tratamiento0.505529
alta potencia0.472015
estadio iia0.534137
presente sección0.449331
tumor haces estrechos0.590695
Drugs Approved0.457515
partes distantes0.468081
Physician Data Query0.588152
Soft Tissue Sarcoma0.634121
radioterapia externa causa0.549798
adultos causa efectos0.535671
área enteras0.486295
siguientes enlaces0.454055
siguientes pruebas0.644136
siguientes sumarios0.574908
siguientes estadios0.500903
siguientes trastornos0.524918
CLICK HERE
3669 National Cancer Institute Html en Hormone Replacement Therapy May Improve Survival for Women with Ovarian Cancer The randomized, controlled Adjuvant Hormone Therapy trial was launched in 1990 to assess the effects of estrogen-alone hormone replacement therapy in women treated for epithelial ovarian cancer.
cancer prevention trials0.416255
Rosalind A. Eeles0.411778
surgical treatment0.379516
estrogen-alone hormone replacement0.439159
HRT0.650737
control group0.489038
HRT group0.449172
ovarian function0.415733
menopausal symptoms0.542367
relapse-free survival0.465056
Cancer Therapy Evaluation0.421244
overall survival0.581691
ovarian estrogen0.432665
ovarian cancer0.928941
ovarian cancer experience0.492272
patients0.45695
randomized clinical trial0.43176
Elise C. Kohn0.397302
adjuvant therapy0.381362
standard treatment options0.433426
median estimated time0.405984
main secondary endpoint0.410696
survival outcomes0.37806
hormone therapy group0.578064
mean overall survival0.423556
potentially relevant factors0.394794
hormone replacement therapy0.634279
Hormone Therapy trial0.447307
hormone therapy groups0.42905
ovarian cancer treatment0.476999
treatment groups0.365534
women0.520693
mean relapse-free survival0.417235
random assignment0.405372
comfortable offering patients0.408947
additional health benefits0.409837
adverse health effects0.418883
Cancer Research0.418301
severe menopausal symptoms0.511618
epithelial ovarian cancer0.775578
postmenopausal women0.378934
trial results0.36603
breast cancer0.41792
transient ischemic attack0.398107
treatment effects0.367465
study authors0.552833
Premenopausal women0.389334
similar survival0.379958
statistically significant differences0.397215
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.